March 10 (Reuters) - Farmaforce Ltd (FFC) : FOR H2, ANTICIPATING AGGRESSIVE REVENUE INCREASE OF 45.5% VERSUS 2H FY19 FY20 REVENUE OUTLOOK IS PROJECTED TO COME IN AT A GROWTH RATE OF 22.2% VERSUS FY19
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status